v3.26.1
Consolidated Statement Of Cashflows - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities      
Net income (loss) $ 2,512,000 $ (91,087,000) $ (18,515,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 47,346,000 33,721,000 23,665,000
Impairment loss (Note 10) 4,035,000 18,863,000 0
Movement in allowance for credit losses 12,796,000 8,011,000 5,158,000
Fair value adjustment related to financial liabilities (238,000) (120,000) (853,000)
Change in fair value of equity securities (Note 6 and 9) (2,593,000) 59,828,000 0
Other income (3,883,000) 0 0
Loss on disposal of equity securities (Note 3) 730,000 0 0
Loss on disposal of equity-accounted investment (Note 9) 584,000 161,000 0
Gain on deconsolidation of subsidiary (848,000) 0 0
(Profit) Loss on disposal of property, plant and equipment (316,000) 13,000 (305,000)
Stock-based compensation charge (Note 17) 6,969,000 9,550,000 7,911,000
(Earnings) Loss from equity-accounted investments (Note 9) (215,000) (114,000) 1,279,000
Reversal of allowance for doubtful loans (1,500,000) 0 (250,000)
Dividends received from equity-accounted investments 105,000 96,000 95,000
Interest payable 20,000 4,723,000 1,119,000
Facility fee amortized (Note 12) 413,000 429,000 443,000
Increase (Decrease) in income taxes payable 402,000 485,000 (400,000)
Deferred tax benefit (9,451,000) (21,739,000) (2,712,000)
Decrease (Increase) in accounts receivable (Note 20) 3,500,000 1,081,000 (10,873,000)
Increase in finance loans receivable (Note 20) (34,421,000) (34,614,000) (10,029,000)
Decrease in inventory 6,704,000 169,000 9,840,000
Increase (Decrease) in accounts payable and other payables 19,793,000 (12,164,000) 23,216,000
Deferred consideration included in other payables (Note 3 and Note 13) 0 13,586,000 0
Net cash provided by (used in) operating activities 52,444,000 (9,122,000) 28,789,000
Cash flows from investing activities      
Capital expenditures (20,646,000) (17,199,000) (12,665,000)
Proceeds from disposal of property, plant and equipment 1,849,000 1,938,000 1,565,000
Acquisition of intangible assets (4,403,000) (3,900,000) (294,000)
Acquisitions, net of cash acquired (Note 3) (11,117,000) (12,946,000) (1,583,000)
Proceeds from disposal of equity securities (Note 6 and 9) 2,971,000 16,441,000 0
Investment in equity securities (450,000) 0 0
Cash disposed on disposal of subsidiary (165,000) 0 0
Proceeds from disposal of equity-accounted investment (Note 9) 0 0 3,508,000
Repayment of loans by equity-accounted investments 0 0 250,000
Acquisition of insurance entity investments (4,598,000) 0 0
Net change in settlement assets 10,822,000 4,324,000 (7,196,000)
Net cash used in investing activities (25,737,000) (11,342,000) (16,415,000)
Cash flows from financing activities      
Proceeds from bank overdraft (Note 12) 123,712,000 98,616,000 182,990,000
Repayment of bank overdraft (Note 12) (129,417,000) (90,309,000) (199,642,000)
Long-term borrowings utilized (Note 12) 6,949,000 190,061,000 23,728,000
Repayment of long-term borrowings (Note 12) (13,741,000) (149,511,000) (20,073,000)
Non-refundable deal origination fees/ guarantee fees (Note 12) (285,000) (970,000) 0
Repurchase of shares of common stock and treasury stock (Note 14) (339,000) (13,660,000) (1,495,000)
Proceeds from exercise of stock options 63,000 116,000 165,000
Acquisition of non-controlling interests (Note 14) (3,538,000) 0 0
Dividends paid to non-controlling interest 0 (432,000) 0
Net change in settlement obligations (10,390,000) (4,179,000) 7,214,000
Net cash (used in) provided by financing activities (26,986,000) 29,732,000 (7,113,000)
Effect of exchange rate changes on cash 5,178,000 1,453,000 2,025,000
Net increase in cash, cash equivalents and restricted cash 4,899,000 10,721,000 7,286,000
Cash, cash equivalents and restricted cash - beginning of period 76,639,000 65,918,000 58,632,000
Cash, cash equivalents and restricted cash - end of period (Note 20) $ 81,538,000 $ 76,639,000 $ 65,918,000